Voyager Therapeutics (VYGR) Receivables - Other (2019 - 2025)
Historic Receivables - Other for Voyager Therapeutics (VYGR) over the last 7 years, with Q3 2025 value amounting to $851000.0.
- Voyager Therapeutics' Receivables - Other fell 7708.67% to $851000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $851000.0, marking a year-over-year decrease of 7708.67%. This contributed to the annual value of $676000.0 for FY2024, which is 7976.65% down from last year.
- As of Q3 2025, Voyager Therapeutics' Receivables - Other stood at $851000.0, which was down 7708.67% from $851000.0 recorded in Q2 2025.
- Voyager Therapeutics' 5-year Receivables - Other high stood at $3.7 million for Q3 2024, and its period low was $151000.0 during Q2 2022.
- Its 5-year average for Receivables - Other is $1.4 million, with a median of $851000.0 in 2025.
- Per our database at Business Quant, Voyager Therapeutics' Receivables - Other crashed by 9877.17% in 2021 and then surged by 211854.3% in 2023.
- Quarter analysis of 5 years shows Voyager Therapeutics' Receivables - Other stood at $732000.0 in 2021, then tumbled by 64.89% to $257000.0 in 2022, then surged by 1200.0% to $3.3 million in 2023, then tumbled by 79.77% to $676000.0 in 2024, then increased by 25.89% to $851000.0 in 2025.
- Its Receivables - Other was $851000.0 in Q3 2025, compared to $851000.0 in Q2 2025 and $487000.0 in Q1 2025.